Not for release, publication or distribution in the United States of America, the United Kingdom,The European Economic Area or Australia
This is a restricted communication and you must not forward it or its contents to any person to whom forwarding it is prohibited by the legends contained therein. In particular, this release and the information contained therein is not being issued and may not be distributed in the United States of America, the United Kingdom, The European Economic Area or Australia and does not constitute an offer of securities for sale in such or any other countries.
Rapid Nutrition Releases Mid-Year Report 2016/17 Highlighting New Stock Listing, Additional Distribution Channels and Extended Product Range
London, March 31, 2017. On the heels of its new listing on the SIX Swiss Exchange, Rapid Nutrition (SIX: RAP) is reporting a mid-year net profit of AUD 508,695 for the period up to December 31, 2016, which represents a 96% increase on the prior comparative period and a top line revenue increase of 39% to AUD 2,071,325 on the prior comparative period.
In addition, Rapid Nutrition recently opened new distribution channels in Asia. Likewise, the company is expanding its product portfolio with the development of a certified organic and vegan range of protein; the new line will be introduced through Rapid Nutrition’s established international distribution network in May 2017.
“Based on the platform and business model we have built and given the momentum of the past six months, the company expects further growth and attractive profits,” said St. Ledger, Managing Director of Rapid Nutrition. “Continued growth for our company and our shareholders and access to new distribution channels and partners remain a priority for the rest of the year as we continue to expand and share our organic healthcare products with consumers worldwide,” St. Ledger added.
Rapid Nutrition’s listing at SIX Swiss Exchange will permit investors a better stock performance comparison with other renowned global brands and market leaders. While gaining access to an area with a stable economic and regulatory environment, Rapid Nutrition will also enjoy a stronger opportunity to raise capital for global expansion plans. The SIX Swiss Exchange based on its own assessment is Europe’s leading exchange for life sciences companies, representing about 40 percent of the European market capitalization of listed companies in this segment.
The H1 report 2016/17 is available on the company’s website:
October 31, 2017 Publication of 2016/17 Full-year Results
December 05, 2017 Annual General Meeting (2017)
About Rapid Nutrition PLC
Rapid Nutrition is a natural healthcare company focused on the research, development and production of a range of life science products. The company was established based on its weight loss supplement range which is exported worldwide and offers consumers a growing range of health and well-being solutions to meet existing and emerging societal health concerns, as well as a providing a number of wider services to the life sciences industry.
For further details, please contact:
Simon St. Ledger, Managing Director
Rapid Nutrition PLC
Phone: +61 7 3200 4222
Andrés Luther, Media Relations
Phone: +41 43 344 4242
Thomas Schneckenburger, Investor Relations
Phone: +41 43 344 4242
This communication expressly or implicitly contains certain forward-looking statements concerning Rapid Nutrition PLC and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of the Rapid Nutrition group to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Rapid Nutrition PLC is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning of article 652a or article 1156 of the Swiss Code of Obligations or a listing prospectus within the meaning of the listing rules of the SIX Swiss Exchange.
This media information is not being issued in countries where the public dissemination of the information contained herein may be restricted or prohibited by law. In particular, this media information is not being issue in the United States of America and should not be distributed to U.S. persons or publications with a general circulation in the United States. Any non-compliance with such restrictions may result in an infringement of U.S. Securities Laws. In particular, the securities of Rapid Nutrition PLC have not been registered under the U.S. Securities laws and may not be offered, sold or delivered within the United States or to U.S. persons absent the registration under or an applicable exemption from the registration requirements of the U.S. Securities laws.
This information is for distribution in the United Kingdom only to: persons who (i) are outside the United Kingdom; (ii) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (Order); (iii) are persons falling within Article 48(2) of the Order (certified high net worth individuals); (iv) are persons falling within Article 49(2) of the Order (high net worth companies, unincorporated associations, etc.); (v) are persons falling within article 50(1) of the Order (sophisticated investors); (vi) are persons falling within article 50A(1) of the Order (self-certified sophisticated investors); (vii) are persons falling within article 51 of the Order (associations of high net worth or sophisticated investors); or (viii) are persons to whom it may otherwise lawfully be communicated (all such persons together being Relevant Persons). This media information is only available to Relevant Persons and persons other than Relevant Persons must not act or rely on it.
This media information may not be provided in Australia other than to select investors ("Exempt Investors") who are able to demonstrate that they (a) fall within one or more of the categories of investors under section 708 of the Australian Corporations Act to whom an offer may be made without disclosure under Part 6D.2 of the Australian Corporations Act and (b) are "wholesale clients" for the purpose of section 761G of the Australian Corporations Act.